Atlas Trials

NTI164 in Autism Spectrum Disorder

Clinical trial NCT07257939 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07257939
Sponsor
Fenix Innovation Group
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
AutismAutism Spectrum DisorderAutism Disorder
Start date
2026-07-01
Primary completion
2029-07-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.